Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

Similar articles for PubMed (Select 19444278)

1.

Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol.

Gan L, Matsuura H, Ichiki T, Yin X, Miyazaki R, Hashimoto T, Cui J, Takeda K, Sunagawa K.

Hypertens Res. 2009 Jul;32(7):542-7. doi: 10.1038/hr.2009.67. Epub 2009 May 15.

PMID:
19444278
2.

Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.

Yan J, Tie G, Park B, Yan Y, Nowicki PT, Messina LM.

J Vasc Surg. 2009 Dec;50(6):1412-22. doi: 10.1016/j.jvs.2009.08.007. Epub 2009 Oct 17.

3.

Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.

Huang PH, Chen JW, Lin CP, Chen YH, Wang CH, Leu HB, Lin SJ.

Cardiovasc Diabetol. 2012 Aug 15;11:99. doi: 10.1186/1475-2840-11-99.

4.

Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice.

Dong L, Kang L, Ding L, Chen Q, Bai J, Gu R, Li L, Xu B.

Microvasc Res. 2011 Nov;82(3):227-36. doi: 10.1016/j.mvr.2011.09.006. Epub 2011 Sep 21.

PMID:
21964072
5.

Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb.

Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, Lecomte-Raclet L, Corbaz A, Clergue M, Duriez M, Barateau V, Akira S, Tedgui A, Tobelem G, Chvatchko Y, Lévy BI.

Circ Res. 2002 Sep 6;91(5):441-8.

6.

Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment.

Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, Duriez M, Tobelem G, Lévy BI.

Am J Pathol. 2004 Feb;164(2):457-66.

7.

Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.

Akar F, Pektas MB, Tufan C, Soylemez S, Sepici A, Ulus AT, Gokalp B, Ozturk K, Surucu HS.

Cardiovasc Drugs Ther. 2011 Apr;25(2):119-31. doi: 10.1007/s10557-010-6255-7.

PMID:
20676927
8.

Kinin receptor agonism restores hindlimb postischemic neovascularization capacity in diabetic mice.

Desposito D, Potier L, Chollet C, Gobeil F Jr, Roussel R, Alhenc-Gelas F, Bouby N, Waeckel L.

J Pharmacol Exp Ther. 2015 Feb;352(2):218-26. doi: 10.1124/jpet.114.219196. Epub 2014 Nov 14.

PMID:
25398240
9.

Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice.

Amin AH, Abd Elmageed ZY, Nair D, Partyka MI, Kadowitz PJ, Belmadani S, Matrougui K.

Lab Invest. 2010 Jul;90(7):985-96. doi: 10.1038/labinvest.2010.86. Epub 2010 May 3.

10.

A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.

Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1315-24. doi: 10.1161/ATVBAHA.109.201327. Epub 2010 Apr 22.

11.

NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.

Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, Waeckel L, Duriez M, Vilar J, Brandes RP, Levy BI, Shah AM, Silvestre JS.

Am J Pathol. 2006 Aug;169(2):719-28.

12.

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.

Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, Maulik N.

Free Radic Biol Med. 2007 Sep 1;43(5):720-9. Epub 2007 May 10.

13.
14.

Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice.

Vulesevic B, McNeill B, Geoffrion M, Kuraitis D, McBane JE, Lochhead M, Vanderhyden BC, Korbutt GS, Milne RW, Suuronen EJ.

Cardiovasc Res. 2014 Feb 1;101(2):306-16. doi: 10.1093/cvr/cvt259. Epub 2013 Nov 20.

15.

Essential role of extracellular SOD in reparative neovascularization induced by hindlimb ischemia.

Kim HW, Lin A, Guldberg RE, Ushio-Fukai M, Fukai T.

Circ Res. 2007 Aug 17;101(4):409-19. Epub 2007 Jun 29.

16.

Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.

Raiter A, Bechor Z, Kleiman M, Leshem-Lev D, Battler A, Hardy B.

Eur J Vasc Endovasc Surg. 2010 Sep;40(3):381-8. doi: 10.1016/j.ejvs.2010.02.003. Epub 2010 Mar 11.

17.

Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia.

Belin de Chantemèle EJ, Ali MI, Mintz J, Stepp DW.

Basic Res Cardiol. 2009 Nov;104(6):707-17. doi: 10.1007/s00395-009-0042-2. Epub 2009 Jun 23.

18.

Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells.

Ohshima M, Li TS, Kubo M, Qin SL, Hamano K.

Circ J. 2009 Jan;73(1):162-6. Epub 2008 Nov 19.

19.

Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice.

Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C.

Diabetologia. 2004 Jun;47(6):1055-63. Epub 2004 Jun 8.

PMID:
15184980
20.

Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.

Huang PH, Sata M, Nishimatsu H, Sumi M, Hirata Y, Nagai R.

Biomed Pharmacother. 2008 Jan;62(1):46-52. Epub 2007 Jul 20.

PMID:
17692499
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk